Evaluating the potential of drug repurposing for rare diseases and Covid-19

by | Mar 31, 2020

Despite the Findacure office being closed due to the situation surrounding Covid-19, we are still working hard to bring our empowerment programme to you through our online webinar programme. Our next webinar will be held from 15:00 to 16:30 on Wednesday 8th April and will focus on drug repurposing for both rare diseases and Covid-19.

With a global pandemic in full swing, there is an essential worldwide research effort to identify potential treatments, cures, and vaccines for Covid-19. At this time of international crisis, a large number of companies and researchers are turning to drug repurposing as a potential solution – but what is repurposing and why is it such an attractive route for drug development at this time?

For many years, Findacure has been discussing and promoting drug repurposing as an essential tool for the development of new treatments for rare diseases. In this webinar, Rick Thompson will outline the basics of this route to drug development, explain why it is such an appealing approach in tackling both covid-19 and rare conditions, and highlight how the rare disease community has been spearheading advances in drug repurposing over the last few years.